Browse by author
Lookup NU author(s): Emerita Professor Katherine Bushby
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The clinical heterogeneity which has long been recognized in the limb-girdle muscular dystrophies (LGMD) has been shown to relate to the involvement of a large number of different genes. At least eight forms of autosomal recessive LGMD and three forms of autosomal dominant disease are now recognized and can be defined by the primary gene or protein involved, or by a genetic localization. These advances have combined the approaches of positional cloning and candidate gene analysis to great effect, with the pivotal role of the dystrophin-associated complex confirmed through the involvement of at least four dystrophin-associated proteins in different subtypes of autosomal recessive LGMD (the sarcoglycanopathies). Two novel mechanisms may have to be postulated to explain the involvement of the calpain 3 and dysferlin genes in other forms of LGMD. Using the diagnostic tools which have become available as a result of this increased understanding, the clinical features of the various subtypes are also becoming clearer, with useful diagnostic and prognostic information at last available to the practising clinician.
Author(s): Bushby KMD
Publication type: Review
Publication status: Published
Journal: Brain
Year: 1999
Volume: 122
Issue: 8
Pages: 1403-1420
Print publication date: 01/08/1999
ISSN (print): 8756-3282
ISSN (electronic): 1873-2763
URL: http://dx.doi.org/10.1093/brain/122.8.1403
DOI: 10.1093/brain/122.8.1403
